High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. - sprookjes - yvandenbroek - TriplyDB

High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.

High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.

http://www.wikidata.org/entity/Q30554334

about

Eosinophilic esophagitis: published evidences for disease subtypes, indications for patient subpopulations, and how to translate patient observations to murine experimental models Eosinophilic esophagitis: New insights in pathogenesis and therapy Eosinophilic esophagitis: From pathophysiology to treatment Eosinophilic Esophagitis Eosinophilic disorders of the gastro-intestinal tract: an update The 2010-2015 Prevalence of Eosinophilic Esophagitis in the USA: A Population-Based Study ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities.Genetic and epigenetic underpinnings of eosinophilic esophagitis Epidemiology of eosinophilic esophagitis.Advances in clinical management of eosinophilic esophagitis Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.The TGFβ1 Promoter SNP C-509T and Food Sensitization Promote Esophageal Remodeling in Pediatric Eosinophilic Esophagitis.The Immunologic Mechanisms of Eosinophilic Esophagitis.Mechanisms of Disease of Eosinophilic Esophagitis.Esophageal squamous papillomas with focal dermal hypoplasia and eosinophilic esophagitis.Unmet therapeutic needs in eosinophilic esophagitis Recent advances in the pathophysiology and management of eosinophilic oesophagitis.Joint hypermobility and headache: understanding the glue that binds the two together--part 1.Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?Eosinophils in mucosal immune responses Gastrointestinal and nutritional issues in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.Association of eosinophilic esophagitis and hypertrophic cardiomyopathy.Eosinophilic oesophagitis: a systematic review for otolaryngologists.Epidemiology and Natural History of Eosinophilic Esophagitis.Pharmacological treatment of eosinophilic gastrointestinal disorders.Eosinophilic oesophagitis.Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.Genetics of eosinophilic esophagitis.Mast cell disorders in Ehlers-Danlos syndrome.Eosinophilic esophagitis phenotypes: Ready for prime time?Eosinophilic Esophagitis: A Primary Disease of the Esophageal Mucosa.Association Between Body Mass Index and Clinical and Endoscopic Features of Eosinophilic Esophagitis.Eosinophilic Esophagitis in Children.Pathophysiology of Eosinophilic Esophagitis.TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.Deeper Than the Epithelium: Role of Matrix and Fibroblasts in Pediatric and Adult Eosinophilic Esophagitis.Pollen-food allergy syndrome is a common allergic comorbidity in adults with eosinophilic esophagitis.Pediatric Eosinophilic Esophagitis Endotypes: Are We Closer to Predicting Treatment Response?

P2860

Q26741559-AFAE19B2-BAB7-4A1C-AF34-B3FDD752A339 Q26768268-F4AA5519-470C-47A0-BBED-0FEFA2188C3E Q26776161-2F3342C1-B76D-4D83-862B-807134A22397 Q26778699-F34AFB4C-0C45-4EFD-9B10-BB0E04F22AE7 Q28066026-8794D23D-19D2-4D6C-833A-B5F3B9CA27D4 Q28389228-AD45A57C-6199-4C85-A3C7-F57302E35D4F Q30274910-1A4F77D1-058E-48C5-B289-0708D5BA19CC Q33594555-4193C32C-C1FD-489D-8093-EA80F65FD304 Q33606257-4827E052-E4D9-4D7A-A442-E36BD4985557 Q33606276-34FF19EB-875A-472A-B6EE-641293400642 Q34619973-08C88270-6FB6-456E-99A8-3522AC0B674E Q34624093-A739F4AE-887A-472B-BD3E-A6193EAEE098 Q35537424-94B9F567-8548-40CF-A4A0-E85A9C0C11C3 Q35866093-8DFA8DA2-1F23-4F86-AE10-4EEE283E6D4F Q37019844-C976A4B2-E2B4-4747-9D27-6699215B7AA2 Q37031313-60021A64-D254-4A57-B131-D085BD8D7324 Q37730900-79084E53-0760-492E-9A8B-7CC328F699BE Q38194025-193C3CE8-F2CD-4DE0-A363-3EE99ECD00C4 Q38200684-C54D4C8C-ABA8-4DB5-89D2-5F55AB1D499A Q38231565-1FE7279A-B65B-43F2-BCE7-B0BDD0CF06C5 Q38240848-91318E29-32A3-4AEC-A87F-733E60157CA0 Q38390424-5F0B614C-F4F4-4F53-B292-28BDB3CD6A0D Q38395358-B5D23B90-A5E7-4B9D-8C58-AD3DBA5E5257 Q38600583-56FBA814-49F9-4919-A47A-DD5358F42FB5 Q38607299-F8796FB8-196B-4795-B507-161E47088045 Q38642524-2967505C-ED9B-4692-9937-59A9CE28D3DF Q38837172-6195EAA5-8596-413F-88E4-0ECDBDDFF947 Q38889213-A8EF6492-DDB7-4D88-912E-F06DCD5257FF Q39113194-F0FC009D-312C-4943-8FDB-6AB4D7BCFA24 Q39146390-A1E257F1-9467-44B8-8289-A9F61F5BDCFD Q39163000-46FF0FCD-58BE-4D4E-A838-A071D8BD1AEB Q39198682-91A12D19-0EC5-4380-A98C-D042171B8065 Q39211686-2BE9EBDF-CA4F-41F5-A041-2931653F40D3 Q39252119-046E4464-BC48-455B-97EA-200252DDDC3E Q39399982-137D9D40-F42F-4E38-9963-68244B0B1ADD Q40114032-6977CC01-1040-44D3-B121-36DE1052817D Q40664203-2A73E778-46B7-4FC9-85A3-62EE690AC0D5 Q42396099-D9CEF7CA-9871-4043-AFBB-80B7B457EF1E Q47684000-9B84810D-9D04-495A-8C35-8C56E2AD9094 Q47767767-C3FF8FC6-1A21-400F-ABD7-91BD85B3FB34

P2860

High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.

http://www.wikidata.org/entity/Q30554334

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

High prevalence of eosinophili ...... d connective tissue disorders.

@ast

High prevalence of eosinophili ...... d connective tissue disorders.

@en

type

label

High prevalence of eosinophili ...... d connective tissue disorders.

@ast

High prevalence of eosinophili ...... d connective tissue disorders.

@en

prefLabel

High prevalence of eosinophili ...... d connective tissue disorders.

@ast

High prevalence of eosinophili ...... d connective tissue disorders.

@en

P1433

Q30554334-2DE60030-69B5-4332-A1DA-A52161C5FC9F

P1476

Q30554334-C6F82AF6-0C98-4897-9208-DF469D53F4E4

P2093

Q30554334-06C6AF14-130E-47A5-B402-4DD99AE6FDFF

Q30554334-0C3DA408-40CA-4D28-AE65-2537C5DB4260

Q30554334-3BE8FC59-91F2-446A-9D08-283DDE465ED8

Q30554334-57FB18DB-6024-407C-BB53-4CFC08F7624B

Q30554334-76920F0A-F60E-4A09-B15D-DD5CD93AB125

Q30554334-7D28D09A-E0F4-4EE7-A8CB-07B9F5181A2B

Q30554334-9D72D2CD-F907-481A-B8E2-3F282C53EA62

Q30554334-A11EB4E8-B835-4B58-9891-767D76AFE339

Q30554334-AA807388-1395-42D7-A19D-9DBE1438CB18

Q30554334-AC034FF0-C11D-445A-9D75-9B758CD141DB

P2860

Q30554334-0345EE58-A545-4733-9A88-E33B6E8AECE7

Q30554334-086C39C5-1A3E-41CA-94DC-D3B065DA7ADC

Q30554334-13A4ADB1-7ABF-467A-AA1A-29479FC23C15

Q30554334-1CEA8C3B-96F7-420E-9FF3-80566DCEEFD6

Q30554334-206F153D-963A-4DF3-B1A8-BBE35BAFFB68

Q30554334-2726AEE7-CC77-4A48-A496-4B3F8CE6BF1A

Q30554334-28AA9B59-B644-40A0-9872-BF3F9CC364BE

Q30554334-33356A02-0F5C-4FED-936B-FC903B638187

Q30554334-3FA05C87-13BE-45B6-8662-7E3BCC209B25

Q30554334-41D45844-9CD6-4E0D-B097-63683EB54610

P304

Q30554334-CF29D872-67CF-449B-8FBA-427E05ADC568

P31

Q30554334-DE6E5C10-54A9-4A79-951E-C2E981567169

P356

Q30554334-7F6B1964-5E71-41C0-8F66-A42C25323544

P407

Q30554334-61F1C0BA-9634-4B40-99FA-E5A25FB44512

P433

Q30554334-B16CB15C-CE1A-47BF-9572-49AF5DAB6941

P478

Q30554334-D875DA1D-CAF7-4FA4-81B4-040D9E3716A1

P50

Q30554334-64B2E9A8-FFE8-47F5-A3DF-D6BFF0B2209F

Q30554334-E4F1BA09-B4F8-439B-B49B-299C21BACA39

P577

Q30554334-BF3997DD-7BE7-4583-A7E6-838C4DD8AA3F

P698

Q30554334-851298CC-F8D0-493F-AA6E-5E8AB1061EA8

P921

Q30554334-D063E4FF-28E8-4648-A6FC-DE6842405B64

P932

Q30554334-080999DD-FDAD-425E-A44A-43D6557B8817

P356

J.JACI.2013.02.030

P1433

The Journal of Allergy and Clinical Immunology

P1476

High prevalence of eosinophili ...... ed connective tissue disorders

@en

P2093

Brad T Tinkle

http://www.w3.org/2001/XMLSchema#string

Emily M Stucke

http://www.w3.org/2001/XMLSchema#string

James P Franciosi

http://www.w3.org/2001/XMLSchema#string

Karl F von Tiehl

http://www.w3.org/2001/XMLSchema#string

Katherine A Kemme

http://www.w3.org/2001/XMLSchema#string

Keith A Marsolo

http://www.w3.org/2001/XMLSchema#string

Marc E Rothenberg

http://www.w3.org/2001/XMLSchema#string

Margaret H Collins

http://www.w3.org/2001/XMLSchema#string

Molly S Griffith

http://www.w3.org/2001/XMLSchema#string

Philip E Putnam

http://www.w3.org/2001/XMLSchema#string

P2860

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

Marfan's syndrome

Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II

An etiological role for aeroallergens and eosinophils in experimental esophagitis

The revised Ghent nosology for the Marfan syndrome

Common variants at 5q22 associate with pediatric eosinophilic esophagitis

Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome

Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

Integration of clinical and genetic data in the i2b2 architecture.

Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids.

P304

378-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2013.02.030

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Juan Pablo Abonia

P577

2013-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23608731

http://www.w3.org/2001/XMLSchema#string

P921

connective tissue

P932

3807809

http://www.w3.org/2001/XMLSchema#string